Hi Quick - assuming revenue continues to increase as it has, and that company isn't going to raise additional funds - can you ask where management is focusing on redeploying the cash?
Are they going to make a push to execute Rapimeds strategy in China/HK, or are they going to focus on the PIMD/WholesaleRX business which has been compounding nicely?